base-metals-investing Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference 09 January
base-metals-investing Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies 16 December 2025
base-metals-investing Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update 13 November 2025
